Together with azacitidine or decitabine, or low-dose cytarabine in recently diagnosed AML aged ≥ 75 decades or with co-morbidities that preclude using intensive induction chemotherapy Acute leukemia is characterized by a quick increase in the volume of immature blood cells. The crowding that outcomes from this kind of cells tends https://directivepublications.org/journal-of-leukemia-research/